(ATR) AptarGroup - Ratings and Ratios

AptarGroup Inc (NYSE:ATR) stands as a leader in designing and manufacturing advanced solutions for drug delivery, consumer product dispensing, and active material science. Their expertise spans multiple sectors, including pharmaceuticals, beauty, personal care, home care, and food and beverage. Through their segments—Aptar Pharma, Aptar Beauty, and Aptar Closures—they deliver a diverse range of products such as pumps for nasal allergy treatments and metered dose inhaler valves for respiratory conditions like asthma and COPD. Their elastomer solutions are crucial for injectable primary packaging, showcasing their commitment to innovation and quality.

With a strong global presence, AptarGroup serves markets in Asia, Europe, Latin America, and North America. Their headquarters in Crystal Lake, Illinois, has been the hub of their operations since their incorporation in 1992. The companys dedication to R&D and sustainability practices underscores their role as a key player in the supply chain, offering tailored solutions that meet evolving market demands and customer needs.

Investors and fund managers will note AptarGroups financial metrics, which highlight their market position and growth potential. With a market capitalization of $10,410.70 million USD, the company presents a P/E ratio of 31.35 and a forward P/E of 28.74, indicating expectations for continued growth. Their P/B ratio of 4.15 and P/S ratio of 2.91 provide further insight into their valuation, making them a notable consideration for those evaluating industry leaders with a strong financial foundation.